Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100044/S061

PROPEL

Intersect Ent. · Decision date Sep 22, 2026

MEDTECHLEDGER EXPLANATIONP100044/S061

What did the FDA decide?

The FDA record P100044/S061, dated 2026-09-22, is a 30-Day Notice supplement to PMA P100044 for the Propel Product Family, an OWO drug-eluting sinus stent from Intersect Ent. in the ear, nose, and throat specialty. Its supplement reason is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier, with the decision recorded as OK30.

The stated change is approval to implement an automated vision sensor for inspection of correct or incorrect packaging orientation when the product is placed in a shipper. This describes an inspection step tied to packaging orientation in shipping configuration; the record does not identify sensor make, detection method, acceptance criteria, or validation data, and the statement's purpose is not independent proof of safety or clinical effectiveness.

FDA approval order statement

approval to implement an automated vision sensor for inspection of correct or incorrect packaging orientation for the Propel Product Family when placed in a shipper
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Sep 22, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P100044/S061
Regulatory pathway
PMA supplement
Product code
OWO
Decision code
OK30
Decision date
Sep 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug-eluting sinus stent.

Product code
OWO
FDA device class
3

For the original device and its historical approval scope, see PMA P100044. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P100044/S061 received

    Application receipt date recorded by FDA.

  2. P100044/S061 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P100044. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100044

Product / regulatory recordCompanyPathwayDecision dateSource
PROPELP100044
Intersect Ent.PMA approvalAug 11, 2011FDA
Intersect Ent.PMA supplementSep 23, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Intersect Ent.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1555 Adams Dr., Menlo Park, CA, 94025

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records